Home » General World News » Millennials are piling into 2 biotech stocks you’ve probably never heard of (AMRN, GERN)

Millennials are piling into 2 biotech stocks you’ve probably never heard of (AMRN, GERN)





Biotech pharma lab drug development

  • Amarin and Geron are two of the most popular stocks on the free stock-trading app Robinhood.
  • One stock has quadrupled in value in recent weeks while the other has seen its shares crash. In both cases, millennial investors appear to be hoping more gains are in store.
  • Follow Amarin and Geron in real time here.

Every week, Business Insider analyzes what investors on the free stock-trading app Robinhood are buying and selling with the hopes of finding something out of the ordinary.

Usually any changes in the app’s Top-100 list are reflective of broader market movements — read more >>>

Source:: BusinessInsider.Com

Comments are closed.